Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barakat

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Journal of Hepatocellular Carcinoma|September 25, 2023
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular CarcinomaAshraf Omar, Ahmed Kaseb, Tamer Elbaz, et al.
Journal of Viral Hepatitis|January 3, 2026
Outcomes and Survival of Egyptian Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Multicentre Retrospective StudyEman M F Barakat, Mohamed Kohla, Ahmed Tawheed, et al.
Scientific Reports|June 27, 2025
Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patientsEman M F Barakat, Mohamed Kohla, Hossam Dabees, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Journal of Hepatocellular Carcinoma|September 25, 2023
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular CarcinomaAshraf Omar, Ahmed Kaseb, Tamer Elbaz, et al.
Journal of Viral Hepatitis|January 3, 2026
Outcomes and Survival of Egyptian Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Multicentre Retrospective StudyEman M F Barakat, Mohamed Kohla, Ahmed Tawheed, et al.
Scientific Reports|June 27, 2025
Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patientsEman M F Barakat, Mohamed Kohla, Hossam Dabees, et al.
Pageof 11